Aspirin is typically given after PCI for acute coronary syndrome but can lead to major bleeding. Colchicine appears to be safer and may be equally efficacious, pilot data suggest.
A real-world study has potentially validated a risk model put forward by the European Society of Cardiology for management of acute coronary syndromes without persistent ST-segment elevation.
Income-based disparities in care and outcomes for patients with acute MI are seen around the world, despite vastly different healthcare and social safety net systems, a new study shows.
In a new study that followed patients for 3 years, long-term mortality and de novo recurrent spontaneous coronary artery dissection rates were much lower than previously reported.